Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

PURPOSE: Follicular lymphoma (FL) is the most frequent indolent non-Hodgkin lymphoma. Around 20% of patients suffer early disease progression within 24 months (POD24) of diagnosis. This study examined the significance of circulating tumor DNA (ctDNA) in predicting response to therapy and POD24 in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Miranda, Ismael, Pedrosa, Lucía, Llanos, Marta, Franco, Fernando F., Gómez, Sagrario, Martín-Acosta, Paloma, García-Arroyo, Francisco R., Gumá, Josep, Horcajo, Beatriz, Ballesteros, Ana K., Gálvez, Laura, Martínez, Natividad, Marín, Miguel, Sequero, Silvia, Navarro, Marta, Yanguas-Casás, Natalia, Calvo, Virginia, Rueda-Domínguez, Antonio, Provencio, Mariano, Sánchez-Beato, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811164/
https://www.ncbi.nlm.nih.gov/pubmed/36269794
http://dx.doi.org/10.1158/1078-0432.CCR-22-1654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811164/
https://www.ncbi.nlm.nih.gov/pubmed/36269794
http://dx.doi.org/10.1158/1078-0432.CCR-22-1654

Ejemplares similares